S&P 500   5,078.18 (+0.17%)
DOW   38,972.41 (-0.25%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
S&P 500   5,078.18 (+0.17%)
DOW   38,972.41 (-0.25%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
S&P 500   5,078.18 (+0.17%)
DOW   38,972.41 (-0.25%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)
S&P 500   5,078.18 (+0.17%)
DOW   38,972.41 (-0.25%)
QQQ   437.60 (+0.24%)
AAPL   182.63 (+0.81%)
MSFT   407.48 (-0.01%)
META   487.05 (+1.10%)
GOOGL   138.88 (+0.95%)
AMZN   173.54 (-0.68%)
TSLA   199.73 (+0.17%)
NVDA   787.01 (-0.49%)
NIO   5.78 (+2.30%)
AMD   178.00 (+1.13%)
BABA   77.68 (+1.53%)
T   16.84 (+1.39%)
F   12.01 (+0.50%)
MU   91.85 (+2.67%)
CGC   3.53 (+1.73%)
GE   153.99 (-0.50%)
DIS   109.45 (+1.64%)
AMC   4.81 (+7.86%)
PFE   26.89 (-1.07%)
PYPL   60.16 (+1.40%)
XOM   104.03 (-0.21%)

AdaptHealth (AHCO) Competitors

$10.00
+2.37 (+31.06%)
(As of 02/27/2024 ET)

AHCO vs. ADUS, EHAB, AVAH, BTSG, AMED, QTRX, ZNTL, IMNM, FUSN, and CABA

Should you be buying AdaptHealth stock or one of its competitors? The main competitors of AdaptHealth include Addus HomeCare (ADUS), Enhabit (EHAB), Aveanna Healthcare (AVAH), BrightSpring Health Services (BTSG), Amedisys (AMED), Quanterix (QTRX), Zentalis Pharmaceuticals (ZNTL), Immunome (IMNM), Fusion Pharmaceuticals (FUSN), and Cabaletta Bio (CABA). These companies are all part of the "medical" sector.

AdaptHealth vs.

AdaptHealth (NASDAQ:AHCO) and Addus HomeCare (NASDAQ:ADUS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

AdaptHealth has a beta of 0.91, suggesting that its stock price is 9% less volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 0.95, suggesting that its stock price is 5% less volatile than the S&P 500.

Addus HomeCare has a net margin of 5.61% compared to AdaptHealth's net margin of -13.68%. Addus HomeCare's return on equity of 9.39% beat AdaptHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
AdaptHealth-13.68% 4.09% 1.65%
Addus HomeCare 5.61%9.39%6.45%

AdaptHealth presently has a consensus price target of $12.64, suggesting a potential upside of 65.72%. Addus HomeCare has a consensus price target of $107.00, suggesting a potential upside of 22.52%. Given AdaptHealth's higher probable upside, equities analysts clearly believe AdaptHealth is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AdaptHealth
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38
Addus HomeCare
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

82.7% of AdaptHealth shares are held by institutional investors. Comparatively, 95.3% of Addus HomeCare shares are held by institutional investors. 13.6% of AdaptHealth shares are held by insiders. Comparatively, 4.4% of Addus HomeCare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, AdaptHealth and AdaptHealth both had 8 articles in the media. Addus HomeCare's average media sentiment score of 1.27 beat AdaptHealth's score of -0.26 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AdaptHealth
1 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Addus HomeCare
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

AdaptHealth has higher revenue and earnings than Addus HomeCare. AdaptHealth is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AdaptHealth$3.08B0.34$69.32M-$3.42-2.23
Addus HomeCare$1.03B1.38$46.03M$3.5524.60

Addus HomeCare received 219 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 66.97% of users gave Addus HomeCare an outperform vote while only 57.94% of users gave AdaptHealth an outperform vote.

CompanyUnderperformOutperform
AdaptHealthOutperform Votes
73
57.94%
Underperform Votes
53
42.06%
Addus HomeCareOutperform Votes
292
66.97%
Underperform Votes
144
33.03%

Summary

Addus HomeCare beats AdaptHealth on 13 of the 17 factors compared between the two stocks.


Get AdaptHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AHCO vs. The Competition

MetricAdaptHealthHome health care services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.04B$2.83B$4.97B$7.51B
Dividend YieldN/A0.27%2.90%3.87%
P/E Ratio-2.2313.82179.2413.44
Price / Sales0.341.323,326.94175.92
Price / Cash2.4112.0025.0825.75
Price / Book0.483.514.554.56
Net Income$69.32M-$11.45M$111.00M$210.58M
7 Day Performance5.39%-0.99%1.84%0.37%
1 Month Performance7.62%-2.57%9.58%3.65%
1 Year Performance-65.29%-1.23%11.13%7.02%

AdaptHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADUS
Addus HomeCare
4.4852 of 5 stars
$91.62
-2.8%
$107.00
+16.8%
-16.5%$1.49B$951.12M25.8133,182News Coverage
EHAB
Enhabit
0.8589 of 5 stars
$9.26
-4.4%
$12.80
+38.2%
-39.3%$464.20M$1.08B-6.9111,000Positive News
Gap Down
AVAH
Aveanna Healthcare
0.0747 of 5 stars
$2.28
-4.6%
$1.78
-21.9%
+88.3%$434.86M$1.79B-1.233,700
BTSG
BrightSpring Health Services
0 of 5 stars
$10.43
-2.6%
$16.39
+57.1%
N/A$1.79B$8.42B0.0035,000Upcoming Earnings
Analyst Upgrade
Gap Up
AMED
Amedisys
2.3753 of 5 stars
$93.69
+0.4%
$103.22
+10.2%
+2.6%$3.06B$2.22B1,338.6220,000Earnings Report
QTRX
Quanterix
3.2229 of 5 stars
$26.07
-0.5%
$31.60
+21.2%
+122.8%$986.23M$105.52M-25.31370Upcoming Earnings
News Coverage
ZNTL
Zentalis Pharmaceuticals
1.2562 of 5 stars
$13.82
+6.6%
$38.14
+176.0%
-24.5%$980.67MN/A-2.98156
IMNM
Immunome
0.1793 of 5 stars
$23.00
-11.0%
$19.00
-17.4%
+408.6%$994.75MN/A-12.7137
FUSN
Fusion Pharmaceuticals
1.9577 of 5 stars
$13.46
+11.0%
$13.80
+2.5%
+168.0%$974.64M$1.46M-8.26101
CABA
Cabaletta Bio
1.0931 of 5 stars
$22.70
-0.7%
$29.27
+29.0%
+186.4%$972.70MN/A-13.2792News Coverage

Related Companies and Tools

This page (NASDAQ:AHCO) was last updated on 2/27/2024 by MarketBeat.com Staff